Journal article

IFIT2 Is an Effector Protein of Type I IFN–Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF-α Secretion and LPS-Induced Endotoxin Shock


Authors listSiegfried, Alexandra; Berchtold, Susanne; Manncke, Birgit; Deuschle, Eva; Reber, Julia; Ott, Thomas; Weber, Michaela; Kalinke, Ulrich; Hofer, Markus J.; Hatesuer, Bastian; Schughart, Klaus; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Weber, Friedemann; Hornef, Mathias W.; Autenrieth, Ingo B.; Bohn, Erwin

Publication year2013

Pages3913-3921

JournalThe Journal of Immunology

Volume number191

Issue number7

ISSN0022-1767

DOI Linkhttps://doi.org/10.4049/jimmunol.1203305

PublisherAmerican Association of Immunologists


Abstract

Type I IFN signaling amplifies the secretion of LPS-induced proinflammatory cytokines such as TNF-α or IL-6 and might thus contribute to the high mortality associated with Gram-negative septic shock in humans. The underlying molecular mechanism, however, is ill defined. In this study, we report the generation of mice deficient in IFN-induced protein with tetratricopeptide repeats 2 (Ifit2) and demonstrate that Ifit2 is a critical signaling intermediate for LPS-induced septic shock. Ifit2 expression was significantly upregulated in response to LPS challenge in an IFN-α receptor– and IFN regulatory factor (Irf)9–dependent manner. Also, LPS induced secretion of IL-6 and TNF-α by bone marrow–derived macrophages (BMDMs) was significantly enhanced in the presence of Ifit2. In accordance, Ifit2-deficient mice exhibited significantly reduced serum levels of IL-6 and TNF-α and reduced mortality in an endotoxin shock model. Investigation of the underlying signal transduction events revealed that Ifit2 upregulates Irf3 phosphorylation. In the absence of Irf3, reduced Ifn-β mRNA expression and Ifit2 protein expression after LPS stimulation was found. Also, Tnf-α and Il-6 secretion but not Tnf-α and Il-6 mRNA expression levels were reduced. Thus, IFN-stimulated Ifit2 via enhanced Irf3 phosphorylation upregulates the secretion of proinflammatory cytokines. It thereby amplifies LPS-induced cytokine production and critically influences the outcome of endotoxin shock.




Citation Styles

Harvard Citation styleSiegfried, A., Berchtold, S., Manncke, B., Deuschle, E., Reber, J., Ott, T., et al. (2013) IFIT2 Is an Effector Protein of Type I IFN–Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF-α Secretion and LPS-Induced Endotoxin Shock, The Journal of Immunology, 191(7), pp. 3913-3921. https://doi.org/10.4049/jimmunol.1203305

APA Citation styleSiegfried, A., Berchtold, S., Manncke, B., Deuschle, E., Reber, J., Ott, T., Weber, M., Kalinke, U., Hofer, M., Hatesuer, B., Schughart, K., Gailus-Durner, V., Fuchs, H., de Angelis, M., Weber, F., Hornef, M., Autenrieth, I., & Bohn, E. (2013). IFIT2 Is an Effector Protein of Type I IFN–Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF-α Secretion and LPS-Induced Endotoxin Shock. The Journal of Immunology. 191(7), 3913-3921. https://doi.org/10.4049/jimmunol.1203305


Last updated on 2025-21-05 at 17:07